Cargando…
First person – Jenny Vermeer and Jonathan lent
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Jenny Vermeer and Jonathan lent are co-first authors on ‘A lineage-tracing tool to map the...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406321/ http://dx.doi.org/10.1242/dmm.046292 |
_version_ | 1783567397292081152 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Jenny Vermeer and Jonathan lent are co-first authors on ‘A lineage-tracing tool to map the fate of hypoxic tumour cells’, published in DMM. Jenny conducted the research described in this article while a postdoctoral researcher in the lab of Ruth Muschel at the University of Oxford, Oxford, UK. She is now a project leader in the lab of Miranda van der Lee at Byondis, Nijmegen, The Netherlands, investigating new targets, particularly in cancer, that will lead to novel treatments. Jonathan is a PhD student in the lab of Marc Vooijs at Maastricht University, Maastricht, The Netherlands, investigating new cancer targets and testing possible new interventions with a focus on tumour hypoxia. |
format | Online Article Text |
id | pubmed-7406321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-74063212020-08-06 First person – Jenny Vermeer and Jonathan lent Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Jenny Vermeer and Jonathan lent are co-first authors on ‘A lineage-tracing tool to map the fate of hypoxic tumour cells’, published in DMM. Jenny conducted the research described in this article while a postdoctoral researcher in the lab of Ruth Muschel at the University of Oxford, Oxford, UK. She is now a project leader in the lab of Miranda van der Lee at Byondis, Nijmegen, The Netherlands, investigating new targets, particularly in cancer, that will lead to novel treatments. Jonathan is a PhD student in the lab of Marc Vooijs at Maastricht University, Maastricht, The Netherlands, investigating new cancer targets and testing possible new interventions with a focus on tumour hypoxia. The Company of Biologists Ltd 2020-07-30 /pmc/articles/PMC7406321/ http://dx.doi.org/10.1242/dmm.046292 Text en © 2020. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Jenny Vermeer and Jonathan lent |
title | First person – Jenny Vermeer and Jonathan lent |
title_full | First person – Jenny Vermeer and Jonathan lent |
title_fullStr | First person – Jenny Vermeer and Jonathan lent |
title_full_unstemmed | First person – Jenny Vermeer and Jonathan lent |
title_short | First person – Jenny Vermeer and Jonathan lent |
title_sort | first person – jenny vermeer and jonathan lent |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406321/ http://dx.doi.org/10.1242/dmm.046292 |